As sponsors and CROs continue to prioritize patient centricity in clinical trials, it is little surprise that eConsent has become a driving topic in every conference agenda. In addition to providing a warm and welcoming introduction to the trial, eConsent has consistently demonstrated the ability to improve patient satisfaction, reduce consent-related protocol deviations and support higher retention rates.
Still, common questions remain such as…
- Can I afford it?
- What is the measured ROI?
- How does it change the ICF creation process?
- Does it work globally?
Watch this 45-minute webinar where we discuss benefits for patients, sites and study teams, address common questions and concerns, and present a brief technology demonstration to help you make eConsent decisions for your upcoming trials.